NCT06859437View on ClinicalTrials.gov

Prevention of Clostridium Difficile Infections Using Lactobacillus Plantarum 299v Strain in Nephrology and Transplantation Department

NARecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

October 31, 2027

Study Completion Date

October 31, 2027

Conditions
Clostridioides Difficile Infection
Interventions
DIETARY_SUPPLEMENT

Prevention of C. difficile infections using LP299v strain Placebo

"Patients treated with antibiotics and at high CDI risk (patients after organ transplantation or receiving immunosuppressive therapy for any other reason) will be enroll to study.~One capsule of placebo orally per a day during the entire period of antibiotic therapy."

DIETARY_SUPPLEMENT

Prevention of C. difficile infections using LP299v strain LP299v

"Patients treated with antibiotics and at high CDI risk (patients after organ transplantation or receiving immunosuppressive therapy for any other reason) will be enroll to study.~One capsule of LP299v orally per a day during the entire period of antibiotic therapy."

Trial Locations (1)

40-027

RECRUITING

Department of Nephrology, Transplantation and Intenal Medicine Medical University of Silesia, Poland

All Listed Sponsors
lead

Medical University of Silesia

OTHER